SeeNext Venture Ltd. 2020-03-18 Health safe CPSC
Health · CPSC · Recall #CPSC-20724
NumbSkin pain relief cream with lidocaine Recall
Issued March 18, 2020 · SeeNext Venture Ltd. · 8,000 units affected
In March 2020, SeeNext Venture Ltd. recalled the NumbSkin pain relief cream with lidocaine, a low-risk health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
What you should do
- 1 Stop using NumbSkin pain relief cream with lidocaine right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SeeNext Venture Ltd. to arrange your replace. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Replace): Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.
Recall details
- Brand
- SeeNext Venture Ltd.
- Category
- Health
- Recall date
- March 18, 2020
- Units affected
- 8,000
- Sold at
- Online at Amazon.com from October 2019 through February 2020 for about $25.
- Recall number
- CPSC-20724
- Made in
- Canada
- Issuing agency
- CPSC
In context
- SeeNext Venture Ltd. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 8,000 units is enough to reach roughly 1 in every 16,375 US households.
- This is the 5th Health recall we've logged in 2020.